Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7171404, 12 pages
https://doi.org/10.1155/2017/7171404
Research Article

Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway

Department of Respiratory Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China

Correspondence should be addressed to Qian Liu; moc.liamtoh@0891_naiquil and Xuejun Guo; moc.621@4691jxoug

Received 11 March 2017; Revised 24 May 2017; Accepted 27 June 2017; Published 13 August 2017

Academic Editor: Jeroen T. Buijs

Copyright © 2017 Sibin Guan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Lozano, M. Naghavi, K. Foreman et al., “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2095–2128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Roth, “Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?” Drugs, vol. 75, no. 1, pp. 1–8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. G. Royce, Y. Moodley, and C. S. Samuel, “Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis,” Pharmacology & Therapeutics, vol. 141, pp. 250–260, 2014. View at Google Scholar
  4. S. S. Sohal, C. Ward, W. Danial, R. Wood-Baker, and E. H. Walters, “Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease,” Expert Review of Respiratory Medicine, vol. 7, no. 3, pp. 275–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. S. Sohal, D. Reid, A. Soltani et al., “Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease,” Respirology, vol. 15, no. 6, pp. 930–938, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas, “TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition,” Molecular Biology of the Cell, vol. 16, no. 4, pp. 1987–2002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Hu, W. Yu, T.-J. Lv, C.-S. Chang, X. Li, and J. Jin, “Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells,” Molecular Membrane Biology, vol. 31, no. 2-3, pp. 103–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Pang, Q. Li, C. Wei et al., “TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China,” PLoS ONE, vol. 9, no. 12, Article ID e112300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Q. Mahmood, D. Reid, C. Ward et al., “Transforming growth factor (TGF) beta1 and Smad signalling pathways: A likely key to EMT-associated COPD pathogenesis,” Respirology (Carlton, Vic.), vol. 22, pp. 133–140, 2017. View at Google Scholar
  10. H. Ikushima and K. Miyazono, “TGFΒ 2 signalling: a complex web in cancer progression,” Nature Reviews Cancer, vol. 10, no. 6, pp. 415–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Han, N. T. Bui, M. T. Ho, Y. M. Kim, M. Cho, and D. B. Shin, “Dexamethasone inhibits TGF-β1-induced cell migration by regulating the ERK and AKT pathways in human colon cancer cells via CYR61,” Cancer Research and Treatment, vol. 48, no. 3, pp. 1141–1153, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-H. Park, J. Yoon, K. Y. Lee, and B. Park, “Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways,” Biochimie, vol. 113, article no. 4678, pp. 26–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Iskender, K. Izgi, and H. Canatan, “Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial–mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis,” Molecular and Cellular Biochemistry, vol. 416, no. 1-2, pp. 71–84, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-L. Zhou, Z.-J. Zhou, Z.-Q. Hu et al., “CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling,” Cancer Letters, vol. 358, no. 2, pp. 124–135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Liu, Z. Li, Y. Song et al., “AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer,” Oncotarget, vol. 7, no. 22, pp. 33152–33164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, S. Li, Y. Fan et al., “Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 421–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. T. Nguyen, T. T. Luong, S. Y. Lee et al., “Panax ginseng aqueous extract prevents pneumococcal sepsis in vivo by potentiating cell survival and diminishing inflammation,” Phytomedicine, vol. 22, no. 11, pp. 1055–1061, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Z. Wang, S. Anderson, W. Du, T. C. He, and C. S. Yuan, “Red ginseng and cancer treatment,” Chinese Journal of Natural Medicines, vol. 14, pp. 7–16, 2016. View at Google Scholar
  19. B.-Y. Hu, X.-J. Liu, R. Qiang et al., “Treatment with ginseng total saponins improves the neurorestoration of rat after traumatic brain injury,” Journal of Ethnopharmacology, vol. 155, no. 2, pp. 1243–1255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kang and H. Min, “Ginseng, the 'immunity boost': The effects of panax ginseng on immune system,” Journal of Ginseng Research, vol. 36, no. 4, pp. 354–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Gross, Z. Shenkman, B. Bleiberg, M. Dayan, M. Gittelson, and R. Efrat, “Ginseng improves pulmonary functions and exercise capacity in patients with COPD,” Monaldi Archives for Chest Disease, vol. 57, pp. 242–246, 2002. View at Google Scholar
  22. D. Sun, B. Wang, M. Shi et al., “Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents,” Phytomedicine, vol. 19, no. 3-4, pp. 369–373, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Li, Y.-X. Sheng, J.-L. Zhang, S.-S. Wang, and D.-A. Guo, “High-performance liquid chromatograhic assay for the active saponins from Panax notoginseng in rat tissues,” Biomedical Chromatography, vol. 20, no. 4, pp. 327–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. F. Xu, X. L. Fang, and D. F. Chen, “Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 187–192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Li, Y. Liu, W. Li et al., “A uplc/ms-based metabolomics investigation of the protective effect of ginsenosides rg1 and rg2 in mice with alzheimer’s disease,” Journal of Ginseng Research, vol. 40, no. 1, pp. 9–17, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Fan, J. Xia, D. Jia et al., “Mechanism of ginsenoside Rg1 renal protection in a mouse model of d-galactose-induced subacute damage,” Pharmaceutical Biology, vol. 54, no. 9, pp. 1815–1821, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bao, Y. Zou, B. Wang et al., “Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages,” International Immunopharmacology, vol. 28, no. 1, pp. 429–434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Yu, X. Yu, D. Guo et al., “Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-β1-induced epithelial to mesenchymal transition in HepG2 cells,” Molecular Medicine Reports, vol. 11, no. 4, pp. 3167–3173, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. X.-S. Xie, M. Yang, H.-C. Liu, C. Zuo, H.-J. Li, and J.-M. Fan, “Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro,” Journal of Ethnopharmacology, vol. 122, no. 1, pp. 35–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Janoff and H. Carp, “Possible mechanisms of emphysema in smokers: cigarette smoke condensate suppresses protease inhibition in vitro,” The American Review of Respiratory Disease, vol. 116, pp. 65–72, 1977. View at Google Scholar
  31. W. Gu, L. Song, X. M. Li, D. Wang, X. J. Guo, and W. G. Xu, “Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways,” Scientific Reports, vol. 5, article 8733, 2015. View at Publisher · View at Google Scholar
  32. J.-Y. Ahn, M.-H. Kim, M.-J. Lim et al., “The inhibitory effect of ginsan on TGF-β mediated fibrotic process,” Journal of Cellular Physiology, vol. 226, no. 5, pp. 1241–1247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Papakonstantinou, G. Karakiulakis, S. Batzios et al., “Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection,” Respiratory Research, vol. 16, no. 1, article 78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. J. L. Shergis, Y. M. Di, A. L. Zhang et al., “Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease,” Complementary Therapies in Medicine, vol. 22, no. 5, pp. 944–953, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. L. Zhao, R. T. Zhu, and Y. L. Sun, “Epithelial-mesenchymal transition in liver fibrosis,” Biomedical Reports, vol. 4, pp. 269–274, 2016. View at Google Scholar
  36. J. Bennett, H. Cassidy, C. Slattery, M. P. Ryan, and T. McMorrow, “Tacrolimus modulates TGF-beta signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells,” Journal of Clinical Medicine, vol. 5, 2016. View at Google Scholar
  37. N. Zidar, E. Boštjančič, M. Jerala et al., “Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transition,” Journal of Cellular and Molecular Medicine, vol. 20, no. 10, pp. 1813–1820, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Q. Mahmood, S. S. Sohal, S. D. Shukla et al., “Epithelial mesenchymal transition in smokers: Large versus small airways and relation to airflow obstruction,” International Journal of COPD, vol. 10, no. 1, pp. 1515–1524, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Ijaz, K. Pazdrak, M. Kalita et al., “Systems biology approaches to understanding epithelial mesenchymal transition (EMT) in mucosal remodeling and signaling in asthma,” World Allergy Organization Journal, vol. 7, no. 1, article no. 13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Sun, J. Chen, W. Qian et al., “Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis,” Journal of Cellular and Molecular Medicine, vol. 20, no. 7, pp. 1234–1246, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Xie, D. Zhou, J. Xiong, J. You, Y. Zeng, and L. Peng, “Paraquat induce pulmonary epithelial-mesenchymal transition through transforming growth factor-β1-dependent mechanism,” Experimental and Toxicologic Pathology, vol. 68, no. 1, pp. 69–76, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. T.-L. Hackett, S. M. Warner, D. Stefanowicz et al., “Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 2, pp. 122–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Gardner, A. J. Fisher, C. Richter et al., “The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation,” American Journal of Pathology, vol. 180, no. 6, pp. 2293–2308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Kasai, J. T. Allen, R. M. Mason, T. Kamimura, and Z. Zhang, “TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT),” Respiratory Research, vol. 6, article 56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-S. Cho, Y.-M. Moon, J.-Y. Um, J.-H. Moon, I.-H. Park, and H.-M. Lee, “Inhibitory effect of ginsenoside Rg1 on extracellular matrix production via extracellular signal-regulated protein kinase/activator protein 1 pathway in nasal polyp-derived fibroblasts,” Experimental Biology and Medicine, vol. 237, no. 6, pp. 663–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Wu, H. Yang, Q. Zhao, X. Zhang, and Y. Lou, “Ginsenoside Rg1 exerts a protective effect against A2535induced toxicity in primary cultured rat cortical neurons through the NF-B/NO pathway,” International Journal of Molecular Medicine, vol. 37, no. 3, pp. 781–788, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Rameshwar, R. Narayanan, J. Qian, T. N. Denny, C. Colon, and P. Gascon, “NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis,” Journal of Immunology, vol. 165, pp. 2271–2277, 2000. View at Google Scholar